Clinical Trials Logo

Filter by:
NCT ID: NCT04837092 Active, not recruiting - Clinical trials for Kidney Transplantation

Phase I/II Study of FR104 First Administration In Patient With Renal Transplantation: FIRsT Study

FIRsT
Start date: June 28, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to investigate the safety, tolerability, pharmacokinetics (PK) of FR104 as well as its potential clinical effect on acute rejection prophylaxis and renal function in a de novo renal transplant population receiving an allograft from standard criteria donors.

NCT ID: NCT04837040 Active, not recruiting - Acromegaly Clinical Trials

A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly

PATHFNDR-1
Start date: May 12, 2021
Phase: Phase 3
Study type: Interventional

A randomized, placebo-controlled study designed to evaluate the safety and efficacy of paltusotine (also known as CRN00808; an orally administered nonpeptide somatostatin agonist) in subjects with acromegaly previously treated with somatostatin receptor ligand (SRL) based treatment regimens.

NCT ID: NCT04835441 Active, not recruiting - Clinical trials for Systemic Lupus Erythematosus

ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus

Synergy
Start date: June 22, 2021
Phase: Phase 2
Study type: Interventional

This is Phase 2, multinational, randomized, blinded study to evaluate the safety, tolerability, efficacy, immunogenicity, pharmacokinetics and pharmacodynamics of ALPN-101 (acazicolcept) in adults with moderate to severe active systemic lupus erythematosus (SLE)

NCT ID: NCT04833582 Active, not recruiting - Osteosarcoma Clinical Trials

A Study of ZN-c3 in Combination With Gemcitabine in Subjects With Osteosarcoma

Start date: August 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is a phase 1/2 study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma.

NCT ID: NCT04831073 Active, not recruiting - Clinical trials for Type A Aortic Dissection

European Registry of Type A Aortic Dissection

ERTAAD
Start date: February 28, 2023
Phase:
Study type: Observational

Acute Stanford type A aortic dissection (TAAD) is a life-threatening condition. Surgery is usually performed as a salvage procedure and is associated with significant postoperative early mortality and morbidity. Understanding the patient's conditions and treatment strategies which are associated with these adverse events is essential for an appropriate management of acute TAAD.

NCT ID: NCT04830436 Active, not recruiting - Stroke Clinical Trials

Impact of Undernutrition in Patients Over 70 Years of Age Thrombolysed and/or Thrombectomized for Stroke

Denut_AVC
Start date: March 31, 2021
Phase:
Study type: Observational

Undernutrition is a frequent problem in hospitals (at least 30% of patients, SENECA-NHANES studies). Its impact on morbidity and mortality is well known in gerontology, oncology and intensive care. There are very few neurovascular studies dealing with the consequences of undernutrition present before the stroke. Indeed, most of the medical literature concerns only undernutrition acquired after a stroke. The investigator propose to analyze medical data from a cohort of patients over 70 years of age thrombolysed and/or thrombectomized in the neurovascular department between the years 2014 and 2019.

NCT ID: NCT04830241 Active, not recruiting - Pregnancy Related Clinical Trials

Neonatal Hypotonia Associated With in Utero Exposure to Antidepressant

Start date: March 25, 2021
Phase:
Study type: Observational

To better characterize the neonatal hypotonia associated with in utero exposure to antidepressants, so far limited to clinical cases, we will perform an observational retrospective pharmacovigilance study, using two databases. First, disproportionality analysis in Vigibase®, the World Health Organization global database, will be perform between antidepressant drugs and neonatal hypotonia . Second, narratives from the French National Pharmacovigilance Database will be extracted.

NCT ID: NCT04830228 Active, not recruiting - Clinical trials for Peripheral Artery Disease

BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions

BIONETIC-I
Start date: August 10, 2021
Phase:
Study type: Observational

BIOTRONIK cobalt chromium balloon-expandable Dynetic-35 stent in association with Passeo-35 Xeo peripheral dilation catheter for the treatment of peripheral iliac lesions

NCT ID: NCT04827719 Active, not recruiting - Clinical trials for Acute Myeloid Leukemia

BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS

Start date: May 1, 2021
Phase: Phase 2
Study type: Interventional

To assess the efficacy, and safety of BST-236 in patients unfit for intensive chemotherapy with AML or HR MDS that failed or relapsed following first line therapy

NCT ID: NCT04827576 Active, not recruiting - Solid Tumor Clinical Trials

Study of Magrolimab in Patients With Solid Tumors

ELEVATELung&UC
Start date: October 1, 2021
Phase: Phase 2
Study type: Interventional

The goals of this clinical study are to learn about the safety, tolerability, dosing and effectiveness of magrolimab in combination with docetaxel in patients with solid tumors.